Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 137

Emailed: 0

PDF Downloaded: 577


Agarwal and Sablania: Follow up of serum ferritin levels in myocardial infarction in Indian males


Introduction

It has been gauge that 12.2% of passing happen from ischemic coronary illness that has been a main source of death in intense myocardial localized necrosis (AMI).1 It has been assessed that there could associate with 30 million patients experiencing computer aided design in India.2 Information from the USA propose around 25% of passing’s in the USA are related with coronary illness each year.3 Risk factors for AMI incorporate hypertension, smoking, diabetes, absence of activity, corpulence, high blood cholesterol, horrible eating routine & unnecessary liquor intake.4, 5

Iron is engaged with pathogenesis of atherosclerosis & coronary conduit sickness as proposed by Sullivan et al, as iron to be cardiovascular gamble factor. 6 A Finnish report likewise reasoned that iron admission was related with myocardial dead tissue (MI). 7 Another review proposed that age & sex-related expansions in iron stores have been connected to the pathogenesis of a few normal sicknesses, including atherosclerosis. 8, 9 Similarly, though bringing down iron levels by phlebotomy was proposed to be athero-protective. 10

Ferritin is pervasive intracellular protein that stores iron & delivery it in controlled design. The presence of redox-dynamic iron, as well as high articulation levels of H-and L-ferritin in human atherosclerotic sores offered roundabout help for the iron hypothesis. 11, 12 L-ferritin levels are expanded in coronary courses from patients with coronary vein illness (computer aided design), demonstrating that iron aggregates in atherosclerotic plaques. 13 As per these epidemiological examinations, high foundational iron levels, checked by serum ferritin levels or transferrin immersion, decidedly connected with expanded hazard of myocardial infarction. 14, 15

However many examinations have been directed in regards to relationship of ferritin & myocardial injury, a couple of studies have been led in India. Moreover, apparently no review has been directed in Indian subcontinent that has followed up ferritin levels in Intense Myocardial Dead tissue.

Materials and Methods

The study was conducted in Department of Biochemistry, Subharti Medical College, and Meerut on patients who came to attend OPD/emergency with complaints of chest pain between 2014 – 2015. The diagnosis of AMI was confirmed only after complete physical examination, X-Ray, cardiac markers & other routine biochemistry tests/urine microscopy. The study group consisted of 39 male patients of diagnosed AMI & 40 age matched male controls. Blood sample was collected on Day-1 (onset of AMI) & Day-6 of AMI while one sample was collected for control group. Any subject with suspected or diagnosed case of concurrent medical illness as chronic alcoholism, liver disease, neoplastic disease, diabetes mellitus or hemochromatosis were excluded from current study.

The study was approved by Institutional Ethical Committee & informed consent was taken for both cases & controls. The study group was subjected to structured questionnaire (demographic, medical & lifestyle). After the interview, a 5 ml blood sample was collected from each subject in plain vial. The sample was refrigerated & analysis for serum ferritin was performed on the same day. Serum Ferritin was analyzed by Enzyme Linked Fluorescent Assay on Minividas Autoanalyzer from Biomerieux.

Statistical analysis was done using SPSS & Microsoft excels software. In all tests of significance two sided p-values have been reported.

Results

Mean serum ferritin levels at Day-1 was not significantly elevated than controls [58.51 (±18.71) ng/ml in day-1 versus 64.09 (±19.42)]. In contrast serum ferritin levels at Day-6 were significantly elevated than controls [226.68 (±18.71) ng/ml at day-6 versus versus ferritin levels in controls (p < 0.001)]. When ferritin levels at day-1 & day-6 were compared for means, day-6 levels were significantly elevated than controls (p < 0.001). Mean of net increase in ferritin levels was 168 ± 97.75 & when it compared with levels at day-6, it was found that day-6 levels were significantly increased with p value of < 0.05.

Discussion

In the present settled case control concentrate on the accomplice comprised of 39 patients that created AMI (day-1) & they were followed up till 6th day (day-6) including 40 controls that were not followed up. Apparently it is the first such concentrate in quite a while. Serum levels of ferritin on day-1 were not fundamentally changed when contrasted with controls (p=0.19). Though S. Ferritin levels on day-6 were expanded fundamentally in cases than controls (p < 0.001) [Table 1 /Figure 1]. The discoveries in present review have been steady with before concentrates as Bharathi et al., & Shipra et al., viewed serum levels of ferritin as essentially higher in cases when contrasted with controls. 16, 17 Comparably companion concentrate on Finnish men likewise proved high grouping of serum ferritin to be emphatically connected with the rate of MI. 18

Figure 1

Representation of levels of S. Ferritin in controls, day-1, Day-6 & net increase

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/3a87d2ed-1590-4763-b535-33e755a6f73cimage1.png

Table 1

Comparison of variables in AMI at day-1, day-6 and control

Variable

Case

Control

p value

N

39

40

Age

59.15 ± 12.63

59.78 ± 12.63

0.81

Ferritin Levels Day-1 in ng/ml (Mean ± SD)

58.51 ± 18.71

64.09 ± 19.42

0.19

Ferritin Levels Day-6 in ng/ml (Mean ± SD)

226.68 ± 101.28

64.09 ± 19.42

<0.001

Ferritin Levels Day-1 Vs Day-6

< 0.001

Net Increase in Ferritin LevelsϮ

168 ± 97.75

p value when compared with Day-6 = 0.01

[i] * N: Number, ϮNet increase in ferritin level = Levels at day-6 minus levels at day-1

Ferritin levels at day-6 were fundamentally expanded that levels at day-1 (p< 0.001). Expansion in ferritin levels from day-1 to day-6 was determined by deducting levels at day-6 by day-1 (Net expansion in Ferritin levels). It was seen that when net expansion in ferritin levels was contrasted & day-6, it was genuinely critical on day-6, however not exceptionally huge (p< 0.05) [Table 1 /Figure 1]. These finding are predictable with that of Moroz C et al., where it was seen that there was slow expansion in ferritin levels post MI. 19

Iron is a redox dynamic metal & strong impetus. The exchange of electrons between the ferrous & ferric states adds to the arrangement of ROS through the Fenton reaction. 20

Bull LDL is taken up by high-proclivity LDL receptors on macrophages, ultimately driving their advancement into froth cells. Froth cells upregulate proteolytic proteins, for example, grid metalloproteases (MMPs) & corrupt extracellular network structure, prompting plaque crack & MI.21 Ferroptosis is an iron-subordinate type of corruption & portrayed by collection of lipid peroxides. 22

Ferritin articulation is incited simultaneously with movement of injury. Union of apoferritin happens inside macrophages & endothelial cells that could be a defensive system against harming impacts of free iron. 23, 24 Improved ferritin creation in endothelial cells makes them more impervious to oxidative injury that elevates ibuprofen to forestall endothelial harm in cardiovascular disease.25

Conclusion

In conclusion, our data supports that elevated serum ferritin levels are associated with pathogenesis of AMI, though it could not be concluded that it is causal association or outcome of the disease due to limited sample size & inclusion of more variables associated with pathogenesis of atherosclerosis.

Conflict of Interest

None.

Source of Funding

None.

References

1 

IM Lee EJ Shiroma F Lobelo P Puska SN Blair PT Katzmarzyk Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease & life expectancy.theLancet2012380983821929

2 

S Deora T Kumar R Ramalingam Demographic and angiographic profile in premature cases of acute coronary syndrome: analysis of 820 young patients from South IndiaCardiovasc Diagn Ther2016631938

3 

EJ Benjamin MJ Blaha RE Chiuve M Cushman SR Das R Deo Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationCirculation201713510e146603

4 

PK Mehta J Wei NK Wenger Ischemic heart disease in women: A focus on risk factorsTrends Cardiovasc Med201525214051

5 

S Mendis P Puska B Norrving Global atlas on cardiovascular disease prevention & control (PDF) 1st Ed. Geneva. World Health Organization in collaboration with the World Heart Federation & the World Stroke Organization. WHO2011318https://world-heart-federation.org/wp-content/uploads/2021/04/Global-Atlas-on-cardiovascular-disease-prevention-and-control.pdf

6 

JL Sullivan Iron and the sex difference in heart disease riskLancet19811823312934

7 

J T Salonen K Nyyssonen H Korpela J Tuomilehto R Seppanen R Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish menCirculation199286380311

8 

P Wardman LP Candeias Fenton chemistry: an introductionRadiat Res1996145552331

9 

M Navab AM Fogelman JA Berliner MC Territo LL Demer JS Frank Pathogenesis of atherosclerosisAm J Cardiol1995761823

10 

H Zheng R Cable B Spencer N Votto SD Katz Iron stores & vascular function in voluntary blood donorsArterioscler Thromb Vasc Biol2005258157783

11 

C Smith M J Mitchinson O I Aruoma B Halliwell Stimulation of lipid peroxidation & hydroxyl-radical generation by the contents of human atherosclerotic lesionsBiochem J1992286Pt 39015

12 

JH Pang MJ Jiang YL Chen FW Wang DL Wang SH Chu Increased ferritin gene expression in atherosclerotic lesionsJ Clin Invest19969710220412

13 

SA You SR Archacki G Angheloiu CS Moravec S Rao M Kinter Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosisPhysiol. Genomics20031312530

14 

JT Salonen K Nyyssonen H Korpela J Tuomilehto R Seppanen R Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish menCirculation199286380311

15 

HI Morrison RM Semenciw Y Mao DT Wigle Serum iron and risk of fatal acute myocardial infarctionEpidemiology1994522436

16 

BK Bharathi C Shrikant Serum ferritin - a potential threat & risk factor for acute myocardial infarctionIJPBS201331713

17 

Shipra BK Gupta, R Solanki Hi Punia V Agarwal J Kaur Relationship of Lipid Profile & Serum Ferritin levels with Acute Myocardial InfarctionJ Clin Diagn Res2014881013

18 

The Global Burden of Disease: 2004 Update. Geneva: World Health Organization 2008https://www.who.int/publications/i/item/9789241563710

19 

C Moroz H Besseler M Katz I Zahavi H Salman M Djaldetti Molecular & cellular mechanisms of iron homeostasis & toxicity in mammalian cellsBiomed Pharmacother199751312630

20 

RR Crichton S Wilmet R Legssyer RJ Ward Molecular & cellular mechanisms of iron homeostasis & toxicity in mammalian cellsJ Inorg Biochem2002911918

21 

K Sakakura M Nakano F Otsuka E Ladich FD Kolodgie R Virmani Pathophysiology of atherosclerosis plaque progressionHeart Lung Circ2013226399411

22 

BR Stockwell JP Angeli H Bayir AI Bush M Conrad SJ Dixon Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell2017171227385

23 

GM Vercellotti G Balla J Balla K Nath JW Eaton HS Jacob Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endotheliumArtif Cells Blood Substit Immobil Biotechnol199422220713

24 

JH Pang MJ Jiang YL Chen FW Wang DL Wang SH Chu Increased ferritin gene expression in atherosclerotic lesionsJ Clin Invest19969710220412

25 

S Oberle T Polte A Abate HP Podhaisky H Schröder Oberle SPolte TAbate APodhaisky HPSchroder H Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathwayCirc Res1998829101620



jats-html.xsl

© 2023 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)